Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helena Rabie

Showing results (71-80 of 144) with videos related to

Pageof 15
Sort By:
The Pediatric Infectious Disease Journal|March 14, 2023
Decreased Hepatic Steatosis in South African Adolescents With Perinatal HIV Switching to Dolutegravir-containing RegimensPenelope C Rose, Etienne De la Rey Nel, Mark F Cotton, et al.
The Lancet. HIV|December 12, 2018
Lopinavir-ritonavir super-boosting in young HIV-infected children on rifampicin-based tuberculosis therapy compared with lopinavir-ritonavir without rifampicin: a pharmacokinetic modelling and clinical studyHelena Rabie, Paolo Denti, Janice Lee, et al.
Infectious Diseases and Therapy|July 3, 2024
Population Pharmacokinetic Modeling of Abacavir/Dolutegravir/Lamivudine to Support a Fixed-Dose Combination in Children with HIV-1Hardik Chandasana, Sven C van Dijkman, Rashmi Mehta, et al.
PLOS Global Public Health|March 28, 2024
The socioeconomic impact of the COVID-19 lockdown on families affected by childhood respiratory illnesses in Cape Town, South AfricaMichaile G Anthony, Graeme Hoddinott, Margaret Van Niekerk, et al.
Tropical Medicine & International Health : TM & IH|September 15, 2012
The role of targeted viral load testing in diagnosing virological failure in children on antiretroviral therapy with immunological failureMary-Ann Davies, Andrew Boulle, Karl Technau, et al.
British Journal of Clinical Pharmacology|July 14, 2021
Abacavir pharmacokinetics in African children living with HIV: A pooled analysis describing the effects of age, malnutrition and common concomitant medicationsTjokosela Tikiso, Helen McIlleron, David Burger, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 26, 2010
Virologic failure and second-line antiretroviral therapy in children in South Africa--the IeDEA Southern Africa collaborationMary-Ann Davies, Harry Moultrie, Brian Eley, et al.
BMC Pediatrics|May 27, 2026
Neonatal HIV prophylaxis is associated with accelerated presentation and clinical progression of MPV17-related mitochondrial neurohepatopathyPenelope C Rose, Helena Rabie, Ronalda de Lacy, et al.
Tropical Medicine & International Health : TM & IH|August 13, 2011
Accuracy of immunological criteria for identifying virological failure in children on antiretroviral therapy - the IeDEA Southern Africa CollaborationMary-Ann Davies, Andrew Boulle, Brian Eley, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|February 5, 2010
Outcomes of the South African National Antiretroviral Treatment Programme for children: the IeDEA Southern Africa collaborationMary-Ann Davies, Olivia Keiser, Karl Technau, et al.
Pageof 15

Showing results (71-80 of 144) with videos related to

Sort By:
Pageof 15
The Pediatric Infectious Disease Journal|March 14, 2023
Decreased Hepatic Steatosis in South African Adolescents With Perinatal HIV Switching to Dolutegravir-containing RegimensPenelope C Rose, Etienne De la Rey Nel, Mark F Cotton, et al.
The Lancet. HIV|December 12, 2018
Lopinavir-ritonavir super-boosting in young HIV-infected children on rifampicin-based tuberculosis therapy compared with lopinavir-ritonavir without rifampicin: a pharmacokinetic modelling and clinical studyHelena Rabie, Paolo Denti, Janice Lee, et al.
Infectious Diseases and Therapy|July 3, 2024
Population Pharmacokinetic Modeling of Abacavir/Dolutegravir/Lamivudine to Support a Fixed-Dose Combination in Children with HIV-1Hardik Chandasana, Sven C van Dijkman, Rashmi Mehta, et al.
PLOS Global Public Health|March 28, 2024
The socioeconomic impact of the COVID-19 lockdown on families affected by childhood respiratory illnesses in Cape Town, South AfricaMichaile G Anthony, Graeme Hoddinott, Margaret Van Niekerk, et al.
Tropical Medicine & International Health : TM & IH|September 15, 2012
The role of targeted viral load testing in diagnosing virological failure in children on antiretroviral therapy with immunological failureMary-Ann Davies, Andrew Boulle, Karl Technau, et al.
British Journal of Clinical Pharmacology|July 14, 2021
Abacavir pharmacokinetics in African children living with HIV: A pooled analysis describing the effects of age, malnutrition and common concomitant medicationsTjokosela Tikiso, Helen McIlleron, David Burger, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 26, 2010
Virologic failure and second-line antiretroviral therapy in children in South Africa--the IeDEA Southern Africa collaborationMary-Ann Davies, Harry Moultrie, Brian Eley, et al.
BMC Pediatrics|May 27, 2026
Neonatal HIV prophylaxis is associated with accelerated presentation and clinical progression of MPV17-related mitochondrial neurohepatopathyPenelope C Rose, Helena Rabie, Ronalda de Lacy, et al.
Tropical Medicine & International Health : TM & IH|August 13, 2011
Accuracy of immunological criteria for identifying virological failure in children on antiretroviral therapy - the IeDEA Southern Africa CollaborationMary-Ann Davies, Andrew Boulle, Brian Eley, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|February 5, 2010
Outcomes of the South African National Antiretroviral Treatment Programme for children: the IeDEA Southern Africa collaborationMary-Ann Davies, Olivia Keiser, Karl Technau, et al.
Pageof 15